These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29021448)

  • 21. Peritoneovenous shunting for intractable chylous ascites complicated with lymphangioleiomyomatosis.
    Makino Y; Shimanuki Y; Fujiwara N; Morio Y; Sato K; Yoshimoto J; Gunji Y; Suzuki T; Sasaki S; Iwase A; Kawasaki S; Takahashi K; Seyama K
    Intern Med; 2008; 47(4):281-5. PubMed ID: 18277030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pleuro-peritoneal communication through the diaphragm affected with lymphangioleiomyomatosis.
    Takagi Y; Sato T; Morio Y; Kumasaka T; Mitani K; Miyamoto H; Iwakami S; Kodama Y; Onuma E; Seyama K; Takahashi K
    Intern Med; 2010; 49(5):439-45. PubMed ID: 20190480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis.
    Mohammadieh AM; Bowler SD; Silverstone EJ; Glanville AR; Yates DH
    Med J Aust; 2013 Jul; 199(2):121-3. PubMed ID: 23879512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of refractory chylous ascites after Kasai portoenterostomy using octreotide.
    Hwang JB; Choi SO; Park WH
    J Pediatr Surg; 2004 Dec; 39(12):1806-7. PubMed ID: 15616936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of idiopathic plasmacytic lymph-adenopathy with polyclonal hyperimmunoglobulinemia (IPL) associated with pleural and peritoneal chylous effusion].
    Toyoshima T; Sezai S; Marumo K; Shimizu T; Hirano M; Iwase T; Suzuki T; Goto H; Yoshikawa M
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1795-6. PubMed ID: 2625608
    [No Abstract]   [Full Text] [Related]  

  • 26. Octreotide therapy for the management of refractory chylous ascites after a staging operation for endometrial adenocarcinoma.
    Kim EA; Park H; Jeong SG; Lee C; Lee JM; Park CT
    J Obstet Gynaecol Res; 2014 Feb; 40(2):622-6. PubMed ID: 24118223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.
    Freitas CS; Baldi BG; Araújo MS; Heiden GI; Kairalla RA; Carvalho CR
    J Bras Pneumol; 2015; 41(3):275-80. PubMed ID: 26176526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chylous ascites caused by portal vein thrombosis treated with octreotide.
    Leong RW; House AK; Jeffrey GP
    J Gastroenterol Hepatol; 2003 Oct; 18(10):1211-3. PubMed ID: 12974913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OK-432 therapy for chylous pleural effusion or ascites associated with lymphatic malformations.
    Ono S; Iwai N; Chiba F; Furukawa T; Fumino S
    J Pediatr Surg; 2010 Sep; 45(9):e7-10. PubMed ID: 20850615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis.
    Andreou A; Papouli M; Papavasiliou V; Badouraki M
    Am J Perinatol; 2005 Nov; 22(8):401-4. PubMed ID: 16283598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
    Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF
    Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful management of chylous ascites with total parenteral nutrition and octreotide in children.
    Yang C; Zhang J; Wang S; Li CC; Kong XR; Zhao Z
    Nutr Hosp; 2013 Nov; 28(6):2124-7. PubMed ID: 24506391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Postoperative refractory chylothorax which was improved by octreotide acetate].
    Gabe A; Seki M; Taira N; Katsura M; Ishida T; Kang Y; Kubota T; Yamashiro T; Uehara T; Sunagawa T; Ohkubo K
    Kyobu Geka; 2012 Mar; 65(3):230-3. PubMed ID: 22374601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytologic, immunocytochemical and ultrastructural characterization of lymphangioleiomyomatosis cell clusters in chylous effusions of patients with lymphangioleiomyomatosis.
    Mitani K; Kumasaka T; Takemura H; Hayashi T; Gunji Y; Kunogi M; Akiyoshi T; Takahashi K; Suda K; Seyama K
    Acta Cytol; 2009; 53(4):402-9. PubMed ID: 19697724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis.
    Cai X; Pacheco-Rodriguez G; Haughey M; Samsel L; Xu S; Wu HP; McCoy JP; Stylianou M; Darling TN; Moss J
    Chest; 2014 Jan; 145(1):108-112. PubMed ID: 24051985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide therapy for chylous ascites in a chronic dialysis patient.
    Lee PH; Lin CL; Lai PC; Yang CW
    Nephrology (Carlton); 2005 Aug; 10(4):344-7. PubMed ID: 16109079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chylous ascites after a living-donor liver graft, effectively treated in a child with octreotide.
    Ünlüsoy Aksu A; Demirtaş Z; Eğritaş Gürkan Ö; Dalgıç B; Sözen H; Dalgıç A
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():173-4. PubMed ID: 24635821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.
    Zhou DX; Zhou HB; Wang Q; Zou SS; Wang H; Hu HP
    Dig Dis Sci; 2009 Aug; 54(8):1783-8. PubMed ID: 19051030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus.
    Sakaue T; Tominaga M; Niizeki T; Zaizen Y; Matsukuma K; Koganemaru M; Hoshino T; Torimura T
    Respir Med Case Rep; 2018; 23():86-89. PubMed ID: 29349035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Octreotide treatment for postoperative chylous ascites in an adult].
    Senosiain Lalastra C; Martínez González J; Mesonero Gismero F; Moreira Vicente V
    Gastroenterol Hepatol; 2012 Oct; 35(8):567-71. PubMed ID: 22608492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.